A polyp at her routine colonoscopy came back Stage III.

The situation

Ruth retired from the Carnegie Library in 2018 after thirty-four years as a children's librarian. She has been widowed for six years. Her two sons live in Minneapolis and Denver. Her schedule is the kind a recent widow builds on purpose. Book club on Tuesdays, a long phone call with each son on Sundays, a walk in Schenley Park most mornings. Her primary care doctor talked her into one more colonoscopy at 70 because her father had had colon cancer. The polyp came back invasive, Stage III moderately differentiated adenocarcinoma. The surgeon's office sent her home with a folder, a date six weeks out, and the names of two oncologists they referred to most often.

How Pinnie stepped in

Diane called the morning after Ruth signed up. By Friday she had Ruth in for a second-opinion consult at UPMC Hillman Cancer Center and a same-week consult at Allegheny Health Network. Both teams agreed on a FOLFOX regimen following resection. Ruth's Medicare Advantage plan required prior authorization for the chemo and for the port placement. Diane filed both before the oncology coordinator did, with the clinical justification attached. She had the surgical slides shipped to Hillman ahead of the second-opinion visit so it was a real consult, not a paperwork meeting. When Ruth's sons asked whether one of them needed to move back, Diane scheduled a three-way call to walk through Ruth's actual recovery plan. A visiting nurse on Wednesdays, meal delivery through the plan's supplemental benefit, and a paid driver for every infusion. A CT scan in cycle three flagged a small lung nodule. Diane got the follow-up PET on the schedule in three business days instead of the offered three weeks. The nodule was benign.

Where things are now

Ruth finished six cycles of FOLFOX in November. Her latest scans are clean. She was back at book club for the December meeting. Her sons came for Thanksgiving as a visit, not as a crisis. Diane texts on Tuesdays.